JP2015520763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520763A5 JP2015520763A5 JP2015513217A JP2015513217A JP2015520763A5 JP 2015520763 A5 JP2015520763 A5 JP 2015520763A5 JP 2015513217 A JP2015513217 A JP 2015513217A JP 2015513217 A JP2015513217 A JP 2015513217A JP 2015520763 A5 JP2015520763 A5 JP 2015520763A5
- Authority
- JP
- Japan
- Prior art keywords
- cdb
- administered
- breast
- breast tumor
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 claims description 14
- 208000026310 Breast neoplasm Diseases 0.000 claims description 7
- 206010006187 Breast cancer Diseases 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 claims description 5
- 229960000499 ulipristal acetate Drugs 0.000 claims description 5
- 201000011510 cancer Diseases 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000002207 metabolite Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims 8
- 229940079593 drug Drugs 0.000 claims 4
- 102000036365 BRCA1 Human genes 0.000 claims 1
- 108700040618 BRCA1 Genes Proteins 0.000 claims 1
- 101150072950 BRCA1 gene Proteins 0.000 claims 1
- 108700010154 BRCA2 Genes Proteins 0.000 claims 1
- 101150008921 Brca2 gene Proteins 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- IEXUMDBQLIVNHZ-YOUGDJEHSA-N (8s,11r,13r,14s,17s)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(O)CCCO)[C@@]2(C)C1 IEXUMDBQLIVNHZ-YOUGDJEHSA-N 0.000 description 3
- 229960003248 mifepristone Drugs 0.000 description 3
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 3
- 229950011093 onapristone Drugs 0.000 description 3
- HKDLNTKNLJPAIY-DWWOYTEKSA-N (8s,13s,14s,17r)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=CC(N(C)C)=CC=C1C1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(O)C(C)=O)[C@]2(C)C1 HKDLNTKNLJPAIY-DWWOYTEKSA-N 0.000 description 1
- 206010055113 Breast cancer metastatic Diseases 0.000 description 1
- 230000000708 anti-progestin effect Effects 0.000 description 1
- 239000003418 antiprogestin Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305586.5 | 2012-05-25 | ||
| EP12305586 | 2012-05-25 | ||
| PCT/EP2013/060801 WO2013175009A1 (en) | 2012-05-25 | 2013-05-24 | Ulipristal acetate for prevention and treatment of breast tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015520763A JP2015520763A (ja) | 2015-07-23 |
| JP2015520763A5 true JP2015520763A5 (enExample) | 2016-07-14 |
| JP6322623B2 JP6322623B2 (ja) | 2018-05-09 |
Family
ID=48471021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015513217A Expired - Fee Related JP6322623B2 (ja) | 2012-05-25 | 2013-05-24 | 乳房腫瘍の予防および処置のための酢酸ウリプリスタル |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150133418A1 (enExample) |
| EP (1) | EP2854817B1 (enExample) |
| JP (1) | JP6322623B2 (enExample) |
| KR (1) | KR20150039130A (enExample) |
| AU (1) | AU2013265163B2 (enExample) |
| CA (1) | CA2874530A1 (enExample) |
| ES (1) | ES2672727T3 (enExample) |
| HU (1) | HUE037889T2 (enExample) |
| IL (1) | IL235847B (enExample) |
| WO (1) | WO2013175009A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017216637A2 (en) | 2017-08-04 | 2017-12-21 | Alvogen Malta Operations (Row) Ltd | Tablet form including ulipristal acetate and the methods for its preparation |
| KR102864826B1 (ko) | 2023-02-07 | 2025-09-29 | 재단법인 아산사회복지재단 | 항암제에 대한 치료 반응성을 예측하기 위한 조성물 및 이의 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954490A (en) | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
| US5747282A (en) | 1994-08-12 | 1998-05-05 | Myraid Genetics, Inc. | 17Q-linked breast and ovarian cancer susceptibility gene |
| US5929262A (en) | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
| US5965377A (en) | 1997-03-24 | 1999-10-12 | Baystate Medical Center | Method for determining the presence of mutated BRCA protein |
| US6514713B1 (en) | 2001-07-03 | 2003-02-04 | Hybritech Incorporated | Methods of detecting BRCA1 mutations |
| ES2212912B1 (es) | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
| US20060111577A1 (en) | 2003-02-28 | 2006-05-25 | Kim Hyun K | Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
| WO2007103510A2 (en) * | 2006-03-08 | 2007-09-13 | Danco Laboratories Llc | Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders |
| US8512745B2 (en) | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
-
2013
- 2013-05-24 HU HUE13724304A patent/HUE037889T2/hu unknown
- 2013-05-24 WO PCT/EP2013/060801 patent/WO2013175009A1/en not_active Ceased
- 2013-05-24 KR KR1020147036629A patent/KR20150039130A/ko not_active Abandoned
- 2013-05-24 US US14/403,304 patent/US20150133418A1/en not_active Abandoned
- 2013-05-24 CA CA2874530A patent/CA2874530A1/en not_active Abandoned
- 2013-05-24 AU AU2013265163A patent/AU2013265163B2/en not_active Ceased
- 2013-05-24 ES ES13724304.4T patent/ES2672727T3/es active Active
- 2013-05-24 EP EP13724304.4A patent/EP2854817B1/en not_active Not-in-force
- 2013-05-24 JP JP2015513217A patent/JP6322623B2/ja not_active Expired - Fee Related
-
2014
- 2014-11-23 IL IL235847A patent/IL235847B/en not_active IP Right Cessation
-
2016
- 2016-07-29 US US15/223,066 patent/US9814732B2/en not_active Expired - Fee Related